Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
US-12310992-B2 · May 27, 2025 · US
This page is not indexed by search engines while we improve data quality.
Jeffs Roger patents
Jeffs Roger is listed as an inventor on 26 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Jeffs Roger |
| Total patents | 26 |
| First publication | Jan 1, 2015 |
| Latest publication | May 27, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
US-12274684-B2 · Apr 15, 2025 · US
Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
US-2024131078-A1 · Apr 25, 2024 · US
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
US-2024100003-A1 · Mar 28, 2024 · US
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
US-11839596-B2 · Dec 12, 2023 · US
Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
US-11839631-B2 · Dec 12, 2023 · US
Treatment of pulmonary arterial hypertension with mesenchymal stem cells
US-11666602-B2 · Jun 6, 2023 · US
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
US-2022062210-A1 · Mar 3, 2022 · US
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
US-11141393-B2 · Oct 12, 2021 · US
Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
US-2021030812-A1 · Feb 4, 2021 · US
Recent patents
Latest publications not already listed above.
Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
US-10842823-B2 · Nov 24, 2020 · US
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
US-2019160032-A1 · May 30, 2019 · US
Treatment of pulmonary arterial hypertension with mesenchymal stem cells
US-2019008904-A1 · Jan 10, 2019 · US
Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
US-2018280445-A1 · Oct 4, 2018 · US
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
US-10080730-B2 · Sep 25, 2018 · US
Treatment of pulmonary arterial hypertension with mesenchymal stem cells
US-10071123-B2 · Sep 11, 2018 · US
Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
US-10016463-B2 · Jul 10, 2018 · US
Compounds and methods for delivery of prostacyclin analogs
US-9624156-B2 · Apr 18, 2017 · US
Compounds and methods for delivery of prostacyclin analogs
US-9422223-B2 · Aug 23, 2016 · US
Compounds and methods for delivery of prostacyclin analogs
US-9278901-B2 · Mar 8, 2016 · US
Compounds and methods for delivery of prostacyclin analogs
US-2016051505-A1 · Feb 25, 2016 · US
Compounds and methods for delivery of prostacyclin analogs
US-2016030371-A1 · Feb 4, 2016 · US
Compounds and methods for delivery of prostacyclin analogs
US-9199908-B2 · Dec 1, 2015 · US
Treatment of pulmonary arterial hypertension with mesenchymal stem cells
US-2015246078-A1 · Sep 3, 2015 · US
Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
US-2015216909-A1 · Aug 6, 2015 · US
Compounds and methods for delivery of prostacyclin analogs
US-2015005374-A1 · Jan 1, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| United Therapeutics Corp | 26 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P43/00 | 26 |
| A61P9/00 | 26 |
| A61P9/12 | 26 |
| A61P9/14 | 26 |
| A61K31/557 | 22 |